Back

Fractyl Health shares plunge 68.03% as investors sue over Revita data

Verifying
  • Robbins LLP filed a class action alleging Fractyl Health misled investors about Revita’s effectiveness.
  • 68.03%: Fractyl shares fell to $0.585 on January 29, 2026.
  • Investors seeking lead-plaintiff appointment must contact Robbins LLP by October 20, 2026.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.